Ryan Neilan, MD
Otolaryngology · Shenandoah, TXNPI 1134388382
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Spirair, Inc. at 43.1% of the total. 2025 is the largest year on record at $12,905, 2.8 times the $4,600 reported in 2019. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 171 payments — averaging $184.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spirair, Inc.$14K
- Aerin Medical Inc.$7K
- Acclarent, Inc$5K
- Intersect ENT, Inc.$3K
- Medical Device Business Services, Inc.$738
- Stryker$451
- plus $2K from 13 others
What the payments were for
- Consulting fees$14,24745%
- Travel & lodging$9,18529%
- Food & beverage$8,16526%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spirair, Inc. | 5 | $13,612 |
| Aerin Medical Inc. | 43 | $7,174 |
| Acclarent, Inc | 68 | $5,030 |
| Intersect ENT, Inc. | 7 | $2,680 |
| Medical Device Business Services, Inc. | 1 | $738 |
| Stryker | 5 | $451 |
| Sanofi | 7 | $372 |
| Optinose US, Inc. | 6 | $357 |
| Medtronic | 6 | $327 |
| Hologic Sales And Service, LLC | 4 | $165 |
| Inspire Medical Systems, Inc. | 6 | $161 |
| Baxter Healthcare | 1 | $112 |
| GSK | 2 | $105 |
| Neurent Medical Limited | 2 | $103 |
| Olympus America Inc. | 2 | $99 |
| Hikma Pharmaceuticals USA | 3 | $60 |
| Kaleo, Inc. | 1 | $18 |
| Merck | 1 | $18 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SeptAlign$27,223
- TURBALIGN$23,402
- VIVAER STYLUS$5,022
- RHINAER STYLUS$4,239
- ACCLARENT Balloon Inflation Device$3,450
- PROPEL$2,793
- SINUVA$2,562
- TruDi Nav Cable$860
- TruDi Navigation System$840
- TruDi Nav Suction$738
- ACCLARENT NAVWIRE Sinus Navigation Guidewire$738
- VivAer$550
- RhinAer$550
- XPRESS ENT DILATION SYSTEM$144
- Relieva Spinplus$123
- Acclarent Aera$122
- NUVENT$121
- TISSEEL$112
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM$109
- NSE - NASOPORE/ OTOPORE$109
How this compares
$31,597 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine-FluticasoneAzelastine/Fluticasone | 58 | $7,566 |
| Epinephrine | 14 | $2,472 |
| Azelastine Hcl | 47 | $1,786 |
| Ipratropium Bromide | 40 | $1,417 |
| Fluticasone Propionate | 57 | $719 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $216 |
| Methylprednisolone | 37 | $184 |
| Levofloxacin | 22 | $183 |
| Mupirocin | 24 | $165 |
| Prednisone | 11 | $24 |
| Alprazolam | 17 | $7 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $60 | $2,47214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 729 otolaryngology providers in Texas.
Other otolaryngology in Shenandoah
- Marc DeanFort Worth$486K
- Amber LuongHouston$426K
- Arjuna KuperanHouston$348K
- Ronald KuppersmithCollege Station$325K
- Ron KarniHouston$317K
- Philip ChenSan Antonio$305K
- Jordan RihaniSouthlake$280K
- Keith MathenyFrisco$269K
- Martin CitardiHouston$245K
- James AtkinsSan Antonio$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.